Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Patients with HER2-positive metastatic breast cancer develop brain metastases in up to 30% of cases. The aim of this systematic review and meta-analysis was to determine the effect of different systemic therapies in patients with HER2-positive metastatic breast cancer and brain metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Werter, Inge M., Remmelzwaal, Sharon, Burchell, George L., de Gruijl, Tanja D., Konings, Inge R., van der Vliet, Hans J., Menke-van der Houven van Oordt, C. Willemien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688214/
https://www.ncbi.nlm.nih.gov/pubmed/36428705
http://dx.doi.org/10.3390/cancers14225612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688214/
https://www.ncbi.nlm.nih.gov/pubmed/36428705
http://dx.doi.org/10.3390/cancers14225612

Ejemplares similares